Publication

Divergent alpha-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases

Related publications (36)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Divergent alpha-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases

Graph Chatbot

Chat with Graph Search

Elucidating the Role of Site-Specific Nitration of alpha-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by alpha-synuclein overexpression

Functional interaction of Parkinsons disease-associated LRRK2 with members of the dynamin GTPase superfamily

Exploring the pathological interaction between LRRK2 and alpha-synuclein

Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration

Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo

Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations

Neurodegenerative phenotypes in an A53T-synuclein transgenic mouse model are independent of LRRK2

Elucidating the role of post-translational modifications of alpha-synuclein using semisynthesis

Role of the FoxO3a Transcription Factor in alpha-synuclein Induced Neurodegeneration